The Massachusetts General Hospital Lurie Center for Autism is conducting a clinical trial to learn
if buspirone (anti-anxiety medication) decreases anxiety in youth with autism spectrum
disorder. This is a 16-week treatment study involving 2 in-person visits and bi-weekly remote
check-ins with the study physician. Youth between the ages of 12-17, with autism, and
experiencing anxiety are welcome to participate. Participants will receive care from experts and
up to $225 for study completion.
Name of Organization:
The Massachusetts General Hospital Lurie Center for Autism
For questions, please email::
[email protected]
Study Link:

